CN Patent

CN104016983B — 吡咯并三嗪类衍生物及其制法和用途

Assigned to Shanghai Desano Biological Pharmaceutical Co Ltd · Expires 2018-11-02 · 8y expired

What this patent protects

本发明涉及吡咯并三嗪类衍生物及其制法和用途。具体地，本发明公开的吡咯并三嗪类衍生物，具有明显的酪氨酸激酶抑制活性，是有效的酪氨酸激酶抑制剂，其为发展具有低耐药性或能缓解早期抑制剂耐药性的新型酪氨酸激酶抑制药物提供了新的研究方向和途径，具有广阔的应用前景和药用价值。

USPTO Abstract

本发明涉及吡咯并三嗪类衍生物及其制法和用途。具体地，本发明公开的吡咯并三嗪类衍生物，具有明显的酪氨酸激酶抑制活性，是有效的酪氨酸激酶抑制剂，其为发展具有低耐药性或能缓解早期抑制剂耐药性的新型酪氨酸激酶抑制药物提供了新的研究方向和途径，具有广阔的应用前景和药用价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN104016983B
Jurisdiction
CN
Classification
—
Expires
2018-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Desano Biological Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.